Stockreport

Gilead Eyes $2.2 Billion Autoimmune Push With Ouro Deal [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead Sciences ( NASDAQ:GILD ) shares were unchanged in premarket after the company agreed to acquire autoimmune biotech Ouro Medicines for up to $2.2 billion, includi [Read more]